Mechanism of the maturation process of SARS-CoV 3CL protease

被引:218
作者
Hsu, MF
Kuo, CJ
Chang, KT
Chang, HC
Chou, CC
Ko, TP
Shr, HL
Chang, GG
Wang, AHJ [1 ]
Liang, PH
机构
[1] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan
[2] Acad Sinica, Core Facil Prot Xray Crystallog, Taipei 115, Taiwan
[3] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan
[4] Natl Yang Ming Univ, Fac Life Sci, Taipei 112, Taiwan
关键词
D O I
10.1074/jbc.M502577200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel human coronavirus. Viral maturation requires a main protease (3CL(pro)) to cleave the virus-encoded polyproteins. We report here that the 3CLpro containing additional N- and/or C-terminal segments of the polyprotein sequences undergoes autoprocessing and yields the mature protease in vitro. The dimeric three-dimensional structure of the C145A mutant protease shows that the active site of one protomer binds with the C-terminal six amino acids of the protomer from another asymmetric unit, mimicking the product-bound form and suggesting a possible mechanism for maturation. The P1 pocket of the active site binds the Gln side chain specifically, and the P2 and P4 sites are clustered together to accommodate large hydrophobic side chains. The tagged C145A mutant protein served as a substrate for the wild-type protease, and the N terminus was first digested (55-fold faster) at the Gln(-1)-Ser(1) site followed by the C-terminal cleavage at the Gln(306)-Gly(307) site. Analytical ultracentrifuge of the quaternary structures of the tagged and mature proteases reveals the remarkably tighter dimer formation for the mature enzyme (K-d = 0.35 nM) than for the mutant (C145A) containing 10 extra N- terminal (K-d = 17.2 nM) or C-terminal amino acids (K-d = 5.6 nM). The data indicate that immature 3CLpro can form dimer enabling it to undergo autoprocessing to yield the mature enzyme, which further serves as a seed for facilitated maturation. Taken together, this study provides insights into the maturation process of the SARS 3CLpro from the polyprotein and design of new structure-based inhibitors.
引用
收藏
页码:31257 / 31266
页数:10
相关论文
共 31 条
  • [1] Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
    Anand, K
    Ziebuhr, J
    Wadhwani, P
    Mesters, JR
    Hilgenfeld, R
    [J]. SCIENCE, 2003, 300 (5626) : 1763 - 1767
  • [2] Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain
    Anand, K
    Palm, GJ
    Mesters, JR
    Siddell, SG
    Ziebuhr, J
    Hilgenfeld, R
    [J]. EMBO JOURNAL, 2002, 21 (13) : 3213 - 3224
  • [3] Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro
    Bacha, U
    Barrila, J
    Velazquez-Campoy, A
    Leavitt, SA
    Freire, E
    [J]. BIOCHEMISTRY, 2004, 43 (17) : 4906 - 4912
  • [4] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [5] High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
    Blanchard, JE
    Elowe, NH
    Huitema, C
    Fortin, PD
    Cechetto, JD
    Eltis, LD
    Brown, ED
    [J]. CHEMISTRY & BIOLOGY, 2004, 11 (10): : 1445 - 1453
  • [6] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [7] Involvement of single residue tryptophan 548 in the quaternary structural stability of pigeon cytosolic malic enzyme
    Chang, HC
    Chang, GG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) : 23996 - 24002
  • [8] Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease
    Chou, CY
    Chang, HC
    Hsu, WC
    Lin, TZ
    Lin, CH
    Chang, GG
    [J]. BIOCHEMISTRY, 2004, 43 (47) : 14958 - 14970
  • [9] Strategies in the design of antiviral drugs
    De Clercq, E
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) : 13 - 25
  • [10] Identification of a novel coronavirus in patients with severe acute respiratory syndrome
    Drosten, C
    Günther, S
    Preiser, W
    van der Werf, S
    Brodt, HR
    Becker, S
    Rabenau, H
    Panning, M
    Kolesnikova, L
    Fouchier, RAM
    Berger, A
    Burguière, AM
    Cinatl, J
    Eickmann, M
    Escriou, N
    Grywna, K
    Kramme, S
    Manuguerra, JC
    Müller, S
    Rickerts, V
    Stürmer, M
    Vieth, S
    Klenk, HD
    Osterhaus, ADME
    Schmitz, H
    Doerr, HW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) : 1967 - 1976